Found 497 matching trials
Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL)
PHASE2The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Location
The First Affiliated Hospital of Soochow University
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma
PHASE1This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Location
Shandong Second Provincial General Hospital
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
PHASE1The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive
PHASE1Background:
The National Cancer Institute (NCI) Surgery Branch has develop...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS
PHASE1This is a first-in-human dose escalation/dose expansion study to evaluate t...
Status
Active Not Recruiting
Location
H Lee Moffitt Cancer Center and Research Institute
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation
PHASE1The investigators propose a nonrandomized, Phase I study to assess the safe...
Location
Hammersmith Hospital
Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138
PHASE1RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Location
Chinese PLA General Hospital
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
N/AThe purpose of this study is to assess long-term side effects from subjects...
Status
Active Not Recruiting
Location
Blood and Marrow Transplant Program
Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG
PHASE1A Phase 1 clinical trial to evaluate the safety and early efficacy of CAR T...
Location
King Chulalongkorn Memorial Hospital
Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy
EARLY_PHASE1This is a single arm, open-label, early phase Ⅰ study, to determine the saf...
Location
Hunan Provincial People's Hospital